pipemidic acid has been researched along with norfloxacin in 66 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 45 (68.18) | 18.7374 |
| 1990's | 7 (10.61) | 18.2507 |
| 2000's | 7 (10.61) | 29.6817 |
| 2010's | 7 (10.61) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M | 1 |
| Cecchetti, V; Fravolini, A; Fringuelli, R; Mascellani, G; Pagella, P; Palmioli, M; Segre, G; Terni, P | 1 |
| Irikura, T; Itoh, A; Koga, H; Murayama, S; Suzue, S | 1 |
| Cha, R; Diwadkar, VU; Grucz, RG; Kaatz, GW; Kerns, RJ; Rybak, MJ; Vaka, F; Ward, TD | 1 |
| Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT | 1 |
| Hashida, Y; Konaka, R; Kourai, H; Maseda, H; Shirai, A | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alamry, KA; Birs, AS; Gonzalez, CF; Ibrahim, MA; Katritzky, AR; Panda, SS; Serrano, JC | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Al-Mahmoudy, AMM; Alamry, KA; Asiri, AM; Faidallah, HM; Girgis, AS; Honkanadavar, HH; Ibrahim, TS; Kalmouch, A; Khan, KA; Panda, SS; Samir, A; Thomas, SJ; Tiwari, AD | 1 |
| Chu, XM; Gong, KK; Liang, LL; Liu, W; Sun, KL; Wang, C; Zhao, CY | 1 |
| Ciura, K; Fallarero, A; Fedorowicz, J; Gilbert-Girard, S; Konopacka, A; Lejnowski, D; Morawska, M; Sączewski, J; Savijoki, K; Skok, Ž; Tomašič, T; Waleron, K | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Cortés, R; Lou Arnal, S; Orozco, F; Pascual, T; Sunyer, L | 1 |
| Agen, C; Blandizzi, C; De Bona, M; Del Tacca, M; Natale, G | 1 |
| Shen, XJ; Wu, FY; Yang, JG | 1 |
| Barnett, G; Carbó, M; de la Torre, R; Segura, J | 1 |
| Nishino, T; Obana, Y | 1 |
| Harder, S; Papenburg, A; Staib, AH; Stille, W | 1 |
| Beer, C; Harder, S; Papenburg, A; Shah, PM; Staib, AH; Stille, W | 1 |
| Badenas, JM; Camí, J; Carbó, M; De la Torre, R; Segura, J | 1 |
| Lerk, CF; Stoutenbeek, CP; van Saene, HK; van Saene, JJ | 1 |
| Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL | 2 |
| Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH | 1 |
| Barba, D; Esposito, S; Galante, D; Pennucci, C | 2 |
| Grimm, H | 2 |
| Baldinelli, L; De Santis, S; De Simone, C; Ferrazzi, M; Pugnaloni, L; Sorice, F | 1 |
| Berardi-Grassias, LD; Roy, O | 1 |
| Aoki, T; Masuda, G; Matsubara, Y; Negishi, M; Sagara, H; Seo, T; Shimizu, N; Tagawa, K; Takizawa, Y; Tomizawa, I | 1 |
| Cancet, B; Clave, D; Didier, J; Henry-Ferry, S; Marty, N | 1 |
| Concia, E; Cruciani, M; Monzillo, V; Navarra, A; Tinelli, C | 1 |
| Traub, WH | 2 |
| Daguet, GL; Delisle-Mizon, F; Lesage, D; Vergez, P | 1 |
| Allocati, N; Cellini, L; Di Girolamo, A; Piccolomini, R; Scazzocchio, F; Selan, L | 1 |
| Dubini, F; Riviera, L | 2 |
| Guenounou, M; Kodari, E; Momrikof, V; Ronco, E; Vacheron, F | 1 |
| Dubini, F; Riviera, L; Visconti, A | 1 |
| Hirose, T; Inoue, M; Ito, Y; Kato, H; Mitsuhashi, S; Okezaki, E | 1 |
| Kawane, H; Niki, Y; Soejima, R; Sumi, M; Umeki, S | 1 |
| Boldrini, F; Del Favero, A; Frongillo, RF; Guerciolini, R; Menichetti, F; Pauluzzi, S | 1 |
| Smith, JT | 1 |
| Boronat Tormo, F; Gallego Gómez, J; Gobernado Serrano, M; Jiménez Cruz, JF; Llopis Mínguez, B; Martínez García, R; Oliver Amorós, F | 1 |
| Bonanni, M; Iegri, F; Lorenzi, A; Mascellino, MT | 1 |
| Bryskier, A; Husson, MO; Izard, D; Leclerc, H | 1 |
| Baba, S; Murai, K | 1 |
| Kashimoto, S; Katae, H; Minami, A; Nakamura, S; Nakata, K; Shimizu, M; Takase, Y; Yamagishi, J | 1 |
| Bebear, C; Cantet, P; Quentin, C; Renaudin, H | 1 |
| Ottrad, M; Shah, PM; Stille, W | 1 |
| Inoue, M; Kouno, K; Mitsuhashi, S | 1 |
| Muytjens, HL; van der Ros-van de Repe, J; van Veldhuizen, G | 1 |
| Klesel, N; Limbert, M; Seibert, G | 1 |
| Heessen, FW; Muytjens, HL | 1 |
| Ottnad-Walz, M; Shah, PM; Stille, W | 1 |
| Abe, Y; Hirai, K; Inoue, M; Irikura, T; Ito, A; Mitsuhashi, S; Suzue, S | 1 |
| Castaño Rodríguez, A; Fernández Fernández, A; Fernández Santos, F; Gastañares Hernando, MJ; Gil Fabra, J; Lantero Benedito, M; Martínez Castellanos, F; Otero Mauricio, G; Undabeitia Santisteban, E | 1 |
| Cilla, G; García-Arenzana, JM; Jimenez, D; Pérez-Trallero, E; Urbieta, M | 1 |
| Arriaga-Alba, M; Barrón-Moreno, F; Flores-Paz, R; García-Jiménez, E; Rivera-Sánchez, R | 1 |
| Dong, C; Feng, XH; Li, JQ | 1 |
| Duan, GC; Xi, YL; Zhu, JY | 1 |
| Depta, JP; Pichler, WJ; Schmid, DA | 1 |
| Itoh, T; Mitsumori, K; Moto, M; Sakai, H; Takahashi, M | 1 |
2 review(s) available for pipemidic acid and norfloxacin
| Article | Year |
|---|---|
Quinoline and quinolone dimers and their biological activities: An overview.
Topics: Anti-Bacterial Agents; Antimalarials; Antineoplastic Agents; Bacteria; Dimerization; Humans; Neoplasms; Quinolines; Quinolones | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
6 trial(s) available for pipemidic acid and norfloxacin
| Article | Year |
|---|---|
[Single oral dose of phosphomycin trometamol versus pipemidic acid and norfloxacin in treating uncomplicated low-level urinary tract infections].
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Female; Fosfomycin; Humans; Middle Aged; Norfloxacin; Pipemidic Acid; Prospective Studies; Single-Blind Method; Tromethamine; Urinary Tract Infections | 1992 |
4-quinolones inhibit biotransformation of caffeine.
Topics: Adult; Biotransformation; Caffeine; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Interactions; Enoxacin; Humans; Male; Molecular Structure; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones; Random Allocation; Theophylline | 1988 |
Effect of quinolones on caffeine disposition.
Topics: Adult; Anti-Infective Agents; Caffeine; Drug Interactions; Humans; Male; Norfloxacin; Pipemidic Acid; Random Allocation | 1989 |
[Comparison of clinical efficacy of norfloxacin (NFLX) and pipemidic acid (PPA) in the treatment of infectious enteritis by a double-blind method. The Japan Research Committee of Norfloxacin Research Group Enteritis].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Dysentery, Bacillary; Enteritis; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Nicotinic Acids; Norfloxacin; Pipemidic Acid | 1987 |
Norfloxacin versus pipemidic acid in complicated urinary tract infections due to susceptible pathogens: a comparative clinical trial.
Topics: Clinical Trials as Topic; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Klebsiella; Male; Middle Aged; Nicotinic Acids; Norfloxacin; Pipemidic Acid; Proteus; Urinary Tract Infections; Urine | 1986 |
[Norfloxacin versus pipemidic acid in acute cystitis].
Topics: Acute Disease; Cystitis; Female; Humans; Nicotinic Acids; Norfloxacin; Pipemidic Acid | 1987 |
58 other study(ies) available for pipemidic acid and norfloxacin
| Article | Year |
|---|---|
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
Quinolonecarboxylic acids. 2. Synthesis and antibacterial evaluation of 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acids.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Pyridones; Spectrophotometry, Infrared; Thiazines | 1987 |
Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids.
Topics: Anti-Bacterial Agents; Bacteria; Quinolines; Structure-Activity Relationship | 1980 |
Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cross-Linking Reagents; Dimerization; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Piperazines; Staphylococcus aureus; Structure-Activity Relationship | 2003 |
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones | 2003 |
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cetylpyridinium; Disinfectants; Drug Resistance, Multiple, Bacterial; Membrane Proteins; Mutation; Norfloxacin; Quaternary Ammonium Compounds; Serratia marcescens | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis and antibacterial evaluation of amino acid-antibiotic conjugates.
Topics: Amino Acids; Anti-Bacterial Agents; Bacillus subtilis; Dose-Response Relationship, Drug; Escherichia coli; Metronidazole; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus; Structure-Activity Relationship; Sulfadiazine | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Synthesis, antibacterial properties and 2D-QSAR studies of quinolone-triazole conjugates.
Topics: Anti-Bacterial Agents; Bacteria; Chemistry Techniques, Synthetic; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones; Triazoles | 2018 |
Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents.
Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Quaternary Ammonium Compounds; Quinolones; Structure-Activity Relationship | 2019 |
Effects of quinolone carboxylic acid derivatives on GABAA receptor-mediated stimulation of gastric acid secretion and intestinal motility.
Topics: Acetylcholine; Animals; Deoxyglucose; Female; GABA-A Receptor Antagonists; Gastric Acid; Gastric Mucosa; Gastrointestinal Motility; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscimol; Nalidixic Acid; Norfloxacin; Pipemidic Acid; Rats; Rats, Inbred Strains; Receptors, GABA-A | 1991 |
[Quinolones in the treatment of acute amebic dysentery].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Dysentery, Amebic; Female; Humans; Infant; Male; Metronidazole; Middle Aged; Norfloxacin; Pipemidic Acid; Quinolones | 1991 |
Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
Topics: Caffeine; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Male; Models, Biological; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones | 1990 |
In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Mice; Microbial Sensitivity Tests; Neutropenia; Norfloxacin; Ofloxacin; Pipemidic Acid; Time Factors; Urinary Tract Infections; Uterus | 1989 |
[Gyrase inhibitors modify metabolising processes in the liver].
Topics: Caffeine; Ciprofloxacin; DNA Topoisomerases, Type II; Enoxacin; Humans; Liver; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Topoisomerase II Inhibitors | 1987 |
Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal.
Topics: Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Colistin; Digestive System; Dose-Response Relationship, Drug; Feces; Humans; Nalidixic Acid; Neomycin; Norfloxacin; Pipemidic Acid; Quinolines; Tobramycin | 1985 |
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica | 1985 |
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae | 1985 |
Comparative in vitro studies with 4-quinolone antimicrobials.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1985 |
Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
Topics: Bacteriuria; Cinoxacin; Ciprofloxacin; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pipemidic Acid; Quinolines | 1985 |
[In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
Topics: Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Pseudomonas aeruginosa; Quinolines; Topoisomerase II Inhibitors | 1985 |
Influence of ofloxacin, norfloxacin, nalidixic acid, pyromidic acid and pipemidic acid on human gamma-interferon production and blastogenesis.
Topics: Adult; Anti-Infective Agents; DNA; Humans; In Vitro Techniques; Interferon-gamma; Lymphocyte Activation; Lymphocytes; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Piromidic Acid | 1986 |
[In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
Topics: Acinetobacter; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Bacteria; Immunodiffusion; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Pseudomonas | 1986 |
[Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
Topics: Acinetobacter; Anti-Bacterial Agents; Cross Infection; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nicotinic Acids; Norfloxacin; Pefloxacin; Pipemidic Acid; Pseudomonas aeruginosa; Staphylococcus | 1987 |
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Enoxacin; Female; Humans; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Peptides, Cyclic; Pipemidic Acid; Rifampin; Tetracycline; Tetracycline Resistance; Urinary Tract Infections; Vancomycin; Virginiamycin | 1988 |
Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers.
Topics: Adult; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella; Male; Nicotinic Acids; Norfloxacin; Ofloxacin; Pipemidic Acid; Proteus mirabilis; Pseudomonas aeruginosa; Time Factors | 1988 |
Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Pipemidic Acid; Quinolines; Serratia marcescens | 1985 |
Occurrence of gram negative bacteria in midstream bladder urine and their sensitivity to quinoline derivatives.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pipemidic Acid; Quinolines; Species Specificity; Urinary Tract Infections; Urine | 1985 |
[Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
Topics: Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Pseudomonas; Pseudomonas aeruginosa; Quinolines | 1985 |
In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Pipemidic Acid; Proteus; Providencia; Urinary Tract Infections | 1988 |
Antibacterial activity in human urine of fosfomycin trometamol in an in vitro model of the urinary bladder.
Topics: Administration, Oral; Adolescent; Adult; Bacteria; Cystitis; Drug Combinations; Fosfomycin; Humans; Male; Models, Biological; Norfloxacin; Pipemidic Acid; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urine | 1988 |
Treatment of experimental cystitis in the rat with a single dose of fosfomycin trometamol.
Topics: Administration, Oral; Animals; Bacterial Infections; Cystitis; Drug Combinations; Fosfomycin; Norfloxacin; Pipemidic Acid; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
Topics: Animals; Anti-Infective Agents; Cell Division; Cells, Cultured; Ciprofloxacin; Interleukin-1; Macrophages; Male; Mice; Mice, Inbred DBA; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Spleen | 1987 |
[Experimental cystitis in the rat and the therapeutic effect of a single dose of fosfomycin trometamol].
Topics: Animals; Cystitis; Drug Combinations; Drug Evaluation, Preclinical; Escherichia coli Infections; Fosfomycin; Klebsiella Infections; Norfloxacin; Pipemidic Acid; Proteus Infections; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
In vitro and in vivo activity of NY-198, a new difluorinated quinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Quinolines; Quinolones | 1987 |
New synthetic quinolone antibacterial agents and serum concentration of theophylline.
Topics: Adult; Anti-Infective Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Theophylline | 1987 |
Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Topics: 4-Quinolones; Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fluoroquinolones; Mutation; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1986 |
Antimicrobial activity of norfloxacin in enteric and urinary tract infections: combined effect of norfloxacin with aminoglycosides, tetracycline and chloramphenicol.
Topics: Acinetobacter; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Chloramphenicol; Drug Combinations; Enterobacteriaceae; Gastrointestinal Diseases; Humans; Microbial Sensitivity Tests; Norfloxacin; Pipemidic Acid; Pseudomonas; Tetracycline; Urinary Tract Infections | 1986 |
Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid | 1985 |
Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
Topics: Blood Bactericidal Activity; Ciprofloxacin; Culture Media; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Phagocytosis; Pipemidic Acid; Quinolines; Serratia marcescens; Topoisomerase II Inhibitors | 1984 |
Studies on distribution of two nalidixic acid analogs in otorhinolaryngological field.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Otorhinolaryngologic Diseases; Palate, Soft; Pipemidic Acid; Rabbits; Radiometry; Tissue Distribution | 1982 |
Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Enoxacin; Gentamicins; Male; Mice; Nalidixic Acid; Naphthyridines; Norfloxacin; Pipemidic Acid | 1983 |
[Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
Topics: 4-Quinolones; Anti-Bacterial Agents; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Ureaplasma | 1983 |
In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
Topics: Anti-Bacterial Agents; Bacteria; Cinoxacin; Enterobacter; Escherichia coli; Humans; Klebsiella pneumoniae; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Pipemidic Acid; Pyridazines; Serratia marcescens | 1983 |
In vitro and in vivo antibacterial activity of AT-2266.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Enoxacin; Male; Mice; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Naphthyridines; Norfloxacin; Pipemidic Acid | 1983 |
Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Pipemidic Acid; Quinolines | 1983 |
Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Drug Resistance, Microbial; Lactams; Mice; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid | 1983 |
In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Cinoxacin; Ciprofloxacin; Humans; Nalidixic Acid; Norfloxacin; Pipemidic Acid; Quinolines | 1984 |
In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
Topics: Agar; Anti-Bacterial Agents; Bacteria; Cinoxacin; Culture Media; Humans; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Pipemidic Acid; Pyridazines; Urine | 1983 |
Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Mice; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Pipemidic Acid; Urinary Tract Infections | 1981 |
[Quinolone-resistant Escherichia coli in the health area of a 650-bed hospital].
Topics: Catchment Area, Health; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Hospital Bed Capacity, 500 and over; Humans; Microbial Sensitivity Tests; Norfloxacin; Pipemidic Acid; Retrospective Studies; Spain; Urinary Tract Infections | 1994 |
Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections.
Topics: Anti-Infective Agents; Ciprofloxacin; Data Collection; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Longitudinal Studies; Norfloxacin; Pipemidic Acid; Urinary Tract Infections | 1993 |
Genotoxic evaluation of norfloxacin and pipemidic acid with the Escherichia coli Pol A-/Pol A+ and the ames test.
Topics: Animals; DNA Damage; Escherichia coli; Frameshift Mutation; Mutagenicity Tests; Norfloxacin; Pipemidic Acid; Point Mutation; Poly A; Rats; Salmonella typhimurium | 1998 |
[Study of filter-paper-substrate delay fluorescence of three quinolones].
Topics: Anti-Infective Agents; Filtration; Hydrogen-Ion Concentration; Norfloxacin; Pefloxacin; Pipemidic Acid; Quinolones; Spectrometry, Fluorescence | 2003 |
[Study on the molecular mechanism of quinolone resistance in Shigellae spp].
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pipemidic Acid; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Quinolones; Shigella | 2004 |
T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigen-Presenting Cells; Aza Compounds; Cell Proliferation; Cells, Cultured; Ciprofloxacin; Clone Cells; Cross Reactions; Drug Hypersensitivity; Enoxacin; Female; Fluoroquinolones; Humans; Hypersensitivity, Delayed; Middle Aged; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Patch Tests; Pipemidic Acid; Quinolines; Quinolones; T-Lymphocytes | 2006 |
Liver initiation activity of norfloxacin but not nalidixic acid, pipemidic acid, and ciprofloxacin on in vivo short-term liver initiation assay in rats.
Topics: 2-Acetylaminofluorene; Animals; Anti-Infective Agents; Carbon Tetrachloride; Carcinogens; Ciprofloxacin; Glutathione Transferase; Liver; Male; Nalidixic Acid; Norfloxacin; Pipemidic Acid; Rats; Rats, Inbred F344 | 2006 |